Reported 0 shares, down 152,187 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 0 |
| 2022-03-31 | 3312000 |
| 2022-06-30 | 2784000 |
| 2022-09-30 | 3716000 |
| 2022-12-31 | 1888245 |
| 2023-03-31 | 571515 |
| 2023-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2023 | Reduced | 0 | -152,187 (-100.0%) | 0 | $0 | 2023-08-08 | |
| Q1 2023 | Reduced | 152,187 | -223,975 (-59.5%) | < 0.01% | $571,515 | 2023-05-12 | |
| Q4 2022 | Added | 376,162 | +92,112 (32.4%) | 0.01% | $1,888,245 | 2023-02-13 | |
| Q3 2022 | Added | 284,050 | +66,863 (30.8%) | 0.03% | $3,716,000 | 2022-11-10 | |
| Q2 2022 | Unchanged | 217,187 | 0 (0.0%) | 0.02% | $2,784,000 | 2022-08-03 | |
| Q1 2022 | New | 217,187 | +217,187 (0.0%) | 0.02% | $3,312,000 | 2022-05-13 | |
| Q4 2021 | Reduced | 0 | -564,059 (-100.0%) | 0 | $0 | 2022-02-10 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
133 managers reported NGM BIOPHARMACEUTICALS INC for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Column Group LLC | Unchanged | 18,136,735 | 0 | 18.23% | $46,974,144 | 11 qtrs |
| EcoR1 Capital LLC | Unchanged | 6,435,518 | 0 | 0.41% | $16,667,992 | 6 qtrs |
| BlackRock Inc | Added | 4,633,005 | +526,863 | < 0.01% | $11,999,484 | 17 qtrs |
| VANGUARD GROUP INC | Reduced | 2,793,260 | -885,263 | < 0.01% | $7,234,544 | 17 qtrs |
| StepStone Group LP | Unchanged | 1,573,357 | 0 | 0.75% | $4,074,995 | 8 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Added | 1,138,843 | +200,409 | 0.01% | $2,948,000 | 9 qtrs |
| MORGAN STANLEY | Added | 898,132 | +41,823 | < 0.01% | $2,326,163 | 17 qtrs |
| STATE STREET CORPORATION | Added | 856,566 | +117,214 | < 0.01% | $2,218,506 | 17 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 850,956 | +60,119 | < 0.01% | $2,203,976 | 17 qtrs |
| Nuveen Asset Management LLC | Added | 781,337 | +12,453 | < 0.01% | $2,023,663 | 17 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 08, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.